Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
Stock detail
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
BLFS
BioLife Solutions, Inc.
NASDAQCM
Medical Instruments & Supplies
United States
$35.25
▼
-0.28 (-0.79%)
POST
—
OPEN
$35.07
HIGH
$35.52
LOW
$34.89
PREV CLOSE
$35.53
VOLUME
344.3K
0.31x avg
BID / ASK
25.20 / 35.33
spr 10.13
MARKET CAP
$1.72B
DAY RANGE
$34.89
$35.52
P/E (TTM)
35.25
Fwd 106.8
EPS (TTM)
1.00
DIV YIELD
—
52W HIGH
$38.10
-7.5%
52W LOW
$17.86
+97.4%
BETA
1.92
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$35.25
+0.00
(+0.00%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
BLFS
$35.25
▼
-0.79%
Chart
Valuation
Financials
Peers
News
BLFS · K 線技術分析（即時、可互動）
basic
pro
快速分析（約 90–120 秒）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，約 90–120 秒。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
One-Year Trajectory
RISK-ON
252 BARS · +33.2% YOY
1-year price chart. Started at 26.46, currently 35.25, up 33.2 percent. Range 18.15 to 37.22 over 252 data points.
2025-09-05
$26.46 → $35.25 (+33.2%)
2026-09-04
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Recent News
Loading § Recent News
EDITORIAL · NOT INVESTMENT ADVICE.
Data sources: Finnhub (quote / profile / news / peers) + Yahoo (stats) + SEC EDGAR XBRL (financials + DCF). All values cached for 5 minutes via ISR.
VALUATION
Deterministic Valuation (SEC EDGAR + Finnhub)
RISK-OFF
DCF FV $5.81 · -83.5% VS SPOT
DCF Fair Value
$5.81
DCF vs Spot
-83.5%
Comps Fair Value
—
WACC Used
+7.5%
Terminal g
+3.0%
Verdict: strong-sell
· DCF $5.81 (-83.5%)
⚠ Comparables skipped: no peer multiples or no per-share economics from Finnhub metric endpoint.
FINANCIALS
Multi-Year Financials (SEC XBRL)
RISK-ON
YOY REV +28.9% · 3 FY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
$96.2M
-$4.6M
$20.1M
$10.6M
$405.9M
2024-12
$74.6M
-$20.2M
$8.4M
$5.2M
$399.5M
2023-12
$68.0M
-$68.0M
-$12.5M
-$18.9M
$412.7M
NEWS
Recent News (past 14 days)
CALM
10 HEADLINES · LAST 14 DAYS
Diamond Hill Bets on BioLife Solutions’ (BLFS) High Switching Cost
Insider Monkey · 2026-09-04
BioLife Solutions (BLFS) Is Up 7.2% After Swinging From Loss To Q2 Profit - What's Changed
Simply Wall St. · 2026-08-07
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates
Zacks · 2026-08-06
BioLife Solutions Reports Second Quarter 2026 Financial Results
PR Newswire · 2026-08-06
Repligen (RGEN) Held An M&A Call With BioLife Solutions.
Simply Wall St. · 2026-07-28
Repligen Reports Q2 Revenue Growth and Raises Full-Year 2026 Guidance
InvestorsHub · 2026-07-28
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout
Zacks · 2026-07-23
Jefferies Downgrades BioLife Solutions to Hold From Buy, Adjusts Price Target to $31 From $30
MT Newswires · 2026-07-23